Literature DB >> 34327661

Cytoplasmic FMR1 interacting protein (CYFIP) family members and their function in neural development and disorders.

Ísis Venturi Biembengut1, Isabelle Leticia Zaboroski Silva1, Tatiana de Arruda Campos Brasil de Souza1, Patrícia Shigunov2.   

Abstract

In humans, the cytoplasmic FMR1 interacting protein (CYFIP) family is composed of CYFIP1 and CYFIP2. Despite their high similarity and shared interaction with many partners, CYFIP1 and CYFIP2 act at different points in cellular processes. CYFIP1 and CYFIP2 have different expression levels in human tissues, and knockout animals die at different time points of development. CYFIP1, similar to CYFIP2, acts in the WAVE regulatory complex (WRC) and plays a role in actin dynamics through the activation of the Arp2/3 complex and in a posttranscriptional regulatory complex with the fragile X mental retardation protein (FMRP). Previous reports have shown that CYFIP1 and CYFIP2 may play roles in posttranscriptional regulation in different ways. While CYFIP1 is involved in translation initiation via the 5'UTR, CYFIP2 may regulate mRNA expression via the 3'UTR. In addition, this CYFIP protein family is involved in neural development and maturation as well as in different neural disorders, such as intellectual disabilities, autistic spectrum disorders, and Alzheimer's disease. In this review, we map diverse studies regarding the functions, regulation, and implications of CYFIP proteins in a series of molecular pathways. We also highlight mutations and their structural effects both in functional studies and in neural diseases.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Cytoplasmic FMR1 interacting protein; Neural development; Neural disorders; WAVE regulatory complex

Mesh:

Substances:

Year:  2021        PMID: 34327661     DOI: 10.1007/s11033-021-06585-6

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  75 in total

1.  Impact of autism-associated genetic variants in interaction with environmental factors on ADHD comorbidities: an exploratory pilot study.

Authors:  Regina Waltes; Christine M Freitag; Timo Herlt; Thomas Lempp; Christiane Seitz; Haukur Palmason; Jobst Meyer; Andreas G Chiocchetti
Journal:  J Neural Transm (Vienna)       Date:  2019-11-09       Impact factor: 3.575

Review 2.  The genomics of schizophrenia: Shortcomings and solutions.

Authors:  Chuanjun Zhuo; Weihong Hou; Gongying Li; Fuqiang Mao; Shen Li; Xiaodong Lin; Deguo Jiang; Yong Xu; Hongjun Tian; Wenqiang Wang; Langlang Cheng
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-03-20       Impact factor: 5.067

3.  Cytoplasmic FMRP interacting protein 1/2 (CYFIP1/2) expression analysis in autism.

Authors:  Rezvan Noroozi; Mir Davood Omrani; Arezou Sayad; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  Metab Brain Dis       Date:  2018-05-11       Impact factor: 3.584

Review 4.  Gene mutations in paediatric epilepsies cause NMDA-pathy, and phasic and tonic GABA-pathy.

Authors:  Svetlana Gataullina; Thierry Bienvenu; Rima Nabbout; Gilles Huberfeld; Olivier Dulac
Journal:  Dev Med Child Neurol       Date:  2019-01-25       Impact factor: 5.449

Review 5.  The role of ADHD associated genes in neurodevelopment.

Authors:  Callum Dark; Jihane Homman-Ludiye; Robert J Bryson-Richardson
Journal:  Dev Biol       Date:  2018-03-30       Impact factor: 3.582

Review 6.  Role of Amyloid-β and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade.

Authors:  Walter Gulisano; Daniele Maugeri; Marian A Baltrons; Mauro Fà; Arianna Amato; Agostino Palmeri; Luciano D'Adamio; Claudio Grassi; D P Devanand; Lawrence S Honig; Daniela Puzzo; Ottavio Arancio
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

7.  Expression Analysis of CYFIP1 and CAMKK2 Genes in the Blood of Epileptic and Schizophrenic Patients.

Authors:  Arezou Sayad; Fatemeh Ranjbaran; Soudeh Ghafouri-Fard; Shahram Arsang-Jang; Mohammad Taheri
Journal:  J Mol Neurosci       Date:  2018-07-11       Impact factor: 3.444

8.  Alzheimer-related decrease in CYFIP2 links amyloid production to tau hyperphosphorylation and memory loss.

Authors:  Sachin Suresh Tiwari; Keiko Mizuno; Anshua Ghosh; Wajeeha Aziz; Claire Troakes; Jason Daoud; Vidushi Golash; Wendy Noble; Tibor Hortobágyi; Karl Peter Giese
Journal:  Brain       Date:  2016-08-14       Impact factor: 13.501

Review 9.  The ASD Living Biology: from cell proliferation to clinical phenotype.

Authors:  Eric Courchesne; Tiziano Pramparo; Vahid H Gazestani; Michael V Lombardo; Karen Pierce; Nathan E Lewis
Journal:  Mol Psychiatry       Date:  2018-06-22       Impact factor: 15.992

10.  The autism- and schizophrenia-associated protein CYFIP1 regulates bilateral brain connectivity and behaviour.

Authors:  Nuria Domínguez-Iturza; Adrian C Lo; Disha Shah; Marcelo Armendáriz; Anna Vannelli; Valentina Mercaldo; Massimo Trusel; Ka Wan Li; Denise Gastaldo; Ana Rita Santos; Zsuzsanna Callaerts-Vegh; Rudi D'Hooge; Manuel Mameli; Annemie Van der Linden; August B Smit; Tilmann Achsel; Claudia Bagni
Journal:  Nat Commun       Date:  2019-08-01       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.